Sie suchten nach: 5-Bromo-3-indolyl phosphate, p-toluidine salt

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....

PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...

Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...

Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications Specialty pump tubing is the winner in those challenging applications Masterflex® tubing pumps are ideal for pumping chemicals. The pe...

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Masterflex Connection Newsletter Vol.3-3 - Specialty pump tubing is the winner in those challenging applications Specialty pump tubing is the winner in those challenging applications Masterflex® tubing pumps are ideal for pumping chemicals. The pe...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...